Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,843 | -190,098 | -169,253 | -139,827 | -76,288 |
| Depreciation Amortization | 3,497 | 14,353 | 12,036 | 8,229 | 4,182 |
| Accounts receivable | 3,027 | 1,063 | 1,123 | 7,277 | 2,917 |
| Accounts payable and accrued liabilities | -1,835 | -2,776 | -1,501 | -1,712 | 1,905 |
| Other Working Capital | 363 | -18,595 | -10,901 | -4,784 | 3,072 |
| Other Operating Activity | 3,306 | 106,683 | 98,307 | 85,239 | 48,622 |
| Operating Cash Flow | $-8,485 | $-89,370 | $-70,189 | $-45,578 | $-15,590 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 44,164 | -84,302 | -125,302 | -137,302 | N/A |
| PPE Investments | -1,010 | -3,825 | -3,070 | -1,806 | -868 |
| Investing Cash Flow | $43,154 | $-88,127 | $-128,372 | $-139,108 | $-868 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25,000 | 25,000 | 25,000 | 25,000 |
| Debt Repayment | N/A | -6,838 | -6,838 | -6,838 | -6,838 |
| Common Stock Issued | N/A | 917 | 594 | 497 | N/A |
| Common Stock Repurchased | -2,466 | -563 | N/A | N/A | N/A |
| Other Financing Activity | -92 | 212,242 | 212,272 | 212,374 | -87 |
| Financing Cash Flow | $-2,558 | $230,758 | $231,028 | $231,033 | $18,075 |
| Exchange Rate Effect | 23 | -404 | -719 | -437 | -85 |
| Beginning Cash Position | 82,324 | 29,467 | 29,467 | 29,467 | 29,467 |
| End Cash Position | 114,458 | 82,324 | 61,215 | 75,377 | 30,999 |
| Net Cash Flow | $32,134 | $52,857 | $31,748 | $45,910 | $1,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,485 | -89,370 | -70,189 | -45,578 | -15,590 |
| Capital Expenditure | -1,010 | -3,825 | -3,070 | -1,806 | -868 |
| Free Cash Flow | -9,495 | -93,195 | -73,259 | -47,384 | -16,458 |